Essex Investment Management Co LLC has filed a Form 13F-HR with the U.S. Securities and Exchange Commission (SEC), disclosing its equity holdings as of September 30, 2026. The filing, signed by attorney-in-fact David Rozenson, details a portfolio of 301 separate securities.
The report lists a wide array of holdings across various sectors, including technology, healthcare, and energy. Notable positions include shares in Microsoft Corporation, Alphabet Inc., and Amazon.com Inc. The portfolio also includes significant stakes in companies such as NVIDIA Corporation, Johnson & Johnson, and Merck & Co. Additionally, the filing lists holdings in smaller companies like Adaptive Biotechnologies Corp, Arcutis Biotherapeutics Inc, and Nuvation Bio Inc.
The filing does not provide a total value for the portfolio, but it details the number of shares held for each listed security.
